- Home
- CRNX vs DRRX Comparison
CRNX vs DRRX Comparison
Compare CRNX & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- DRRX
- Stock Information
- Founded
- CRNX 2008
- DRRX 1998
- Country
- CRNX United States
- DRRX United States
- Employees
- CRNX N/A
- DRRX N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- CRNX Health Care
- DRRX Health Care
- Exchange
- CRNX Nasdaq
- DRRX Nasdaq
- Market Cap
- CRNX 2.8B
- DRRX N/A
- IPO Year
- CRNX 2018
- DRRX 2000
- Fundamental
- Price
- CRNX $30.00
- DRRX $0.67
- Analyst Decision
- CRNX Strong Buy
- DRRX Hold
- Analyst Count
- CRNX 10
- DRRX 1
- Target Price
- CRNX $75.00
- DRRX N/A
- AVG Volume (30 Days)
- CRNX 646.9K
- DRRX 44.2K
- Earning Date
- CRNX 08-07-2025
- DRRX 08-12-2025
- Dividend Yield
- CRNX N/A
- DRRX N/A
- EPS Growth
- CRNX N/A
- DRRX N/A
- EPS
- CRNX N/A
- DRRX N/A
- Revenue
- CRNX $760,000.00
- DRRX $1,856,000.00
- Revenue This Year
- CRNX $402.12
- DRRX N/A
- Revenue Next Year
- CRNX $770.88
- DRRX $673.00
- P/E Ratio
- CRNX N/A
- DRRX N/A
- Revenue Growth
- CRNX N/A
- DRRX 79.84
- 52 Week Low
- CRNX $24.10
- DRRX $0.48
- 52 Week High
- CRNX $62.53
- DRRX $1.74
- Technical
- Relative Strength Index (RSI)
- CRNX 44.17
- DRRX 58.87
- Support Level
- CRNX $28.34
- DRRX $0.60
- Resistance Level
- CRNX $30.01
- DRRX $0.67
- Average True Range (ATR)
- CRNX 1.07
- DRRX 0.06
- MACD
- CRNX -0.17
- DRRX 0.01
- Stochastic Oscillator
- CRNX 36.41
- DRRX 47.06
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.